Search results for "Venous thromboembolism"
There will be (less) blood
A new patient blood management program reduced transfusions, length of stay, and cost at one hospital.
https://acphospitalist.acponline.org/archives/2022/02/16/there-will-be-less-blood.htm
16 Feb 2022
Improving in-hospital handoffs
Any physicians who hand off patients may want to consider how well their messages are being understood, especially because patient safety is at stake.
https://acphospitalist.acponline.org/weekly/archives/2019/04/17/4.htm
17 Apr 2019
Puzzling it out together
Hospitalists share strategies for pandemic problems.
https://acphospitalist.acponline.org/archives/2020/10/puzzling-it-out-together.htm
15 Oct 2020
Aspirin, rivaroxaban similarly effective at preventing VTE after total hip or total knee arthroplasty
The trial had a number of limitations, including inclusion of few patients at very high risk of a clot, but the results are still likely to be practice-changing, according to an accompanying editorial.
https://acphospitalist.acponline.org/weekly/archives/2018/02/28/1.htm
28 Feb 2018
Which patients to anticoagulate and how
Updated guidelines, new drugs are among the things to know to treat venous thromboembolism.
https://acphospitalist.acponline.org/archives/2017/06/anticoagulation.htm
15 Jun 2017
ACOVE quality indicators may improve care in hospitalized elderly
Clinicians administered a checklist during rounds, which assessed for prophylaxis against venous thromboembolism, indwelling bladder catheters, mobilization, and delirium evaluation—four commonly encountered components of Assessing Care of Vulnerable Elders (ACOVE).
https://acphospitalist.acponline.org/weekly/archives/2017/07/12/2.htm
12 Jul 2017
Continuing aspirin for no reason?
A speaker made the case for anticoagulant monotherapy in selected patients with stable coronary artery disease and atrial fibrillation during a “Things We Do For No Reason” session at SHM Converge 2022.
https://acphospitalist.acponline.org/archives/2022/04/27/continuing-aspirin-for-no-reason.htm
27 Apr 2022
Apixaban associated with less bleeding than warfarin for VTE in end-stage kidney disease
The use of apixaban among dialysis patients being treated for acute venous thromboembolism (VTE) rose from 2% in 2014 to 47% in 2018, according to an industry-funded retrospective comparison of the drug with warfarin.
https://acphospitalist.acponline.org/archives/2022/08/17/apixaban-associated-with-less-bleeding-than-warfarin.htm
17 Aug 2022
Outcomes of limited cancer screening after unprovoked VTE similar to extensive screening
The prevalence of cancer after venous thromboembolism (VTE) was low in young patients and women receiving estrogen, leading the study authors to question whether screening for occult cancer should be offered to low-risk patients.
https://acphospitalist.acponline.org/weekly/archives/2017/08/23/1.htm
23 Aug 2017
Preop meds, resuscitation champions, and more
Research summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2021/06/in-the-news.htm
15 Jun 2021